Shih-Lung Cheng
8PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jul 29, 2025
Correction: Cheng et al. NICEFIT-A Prospective, Non-Interventional, and Multicentric Study for the Management of Idiopathic Pulmonary Fibrosis with Antifibrotic Therapy in Taiwan. Biomedicines 2022, 10, 2362.Shih-Lung Cheng, Chau-Chyun Sheu, Chih-Feng Chian
|Mar 29, 2023
Pathophysiology, Therapeutic Targets, and Future Therapeutic Alternatives in COPD: Focus on the Importance of the Cholinergic System.Felisbela Gomes, Shih-Lung Cheng
|Oct 27, 2022
Reply to Crimi, C.; Cortegiani, A. Comment on "Liu et al. Application of High-Flow Nasal Cannula in COVID-19: A Narrative Review. Life 2022, 12, 1419".Cheng-Wei Liu, Shih-Lung Cheng
|Oct 27, 2022
NICEFIT-A Prospective, Non-Interventional, and Multicentric Study for the Management of Idiopathic Pulmonary Fibrosis with Antifibrotic Therapy in Taiwan.Shih-Lung Cheng, Chau-Chyun Sheu, Chih-Feng Chian
|Sep 23, 2022
Application of High-Flow Nasal Cannula in COVID-19: A Narrative Review.Cheng-Wei Liu, Shih-Lung Cheng
|Feb 25, 2022
Asthma and COVID-19 Associations: Focus on IgE-Related Immune Pathology.Chung-Jen Wang, Shih-Lung Cheng, Sow-Hsong Kuo
Pageof 2
